Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Use BioMicro's MAUI Array System With NCode miRNA Platform

NEW YORK (GenomeWeb News) – Invitrogen will use BioMicro Systems’ microarray user interface hybridization system with its new NCode miRNA profiling platform, the companies said last week.
 
The companies will co-market BioMicro’s system, called MAUI, with the NCode arrays. 
 
Invitrogen said “preliminary data” shows that using the MAUI system with the NCode arrays results in a 10-fold gain in sensitivity over manual hybridization.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.